Compound Profiles
CJC-1295 (without DAC)
Short-Acting Growth Hormone Releasing Hormone Analog
Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.
Ipamorelin
Growth Hormone Secretagogue | Selective GHRP
Binds selectively to ghrelin receptors in pituitary gland, stimulating natural GH release with direct systemic delivery via injection, consistent GH pulse stimulation, no significant cortisol or prolactin elevation, and minimal hunger response..
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take CJC-1295 (without DAC) with Ipamorelin?
Yes, CJC-1295 (without DAC) and Ipamorelin can generally be taken together. Complementary GH release via different receptor pathways. Popular combination.
Is CJC-1295 (without DAC) and Ipamorelin safe together?
Based on documented research, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.
What are the interactions between CJC-1295 (without DAC) and Ipamorelin?
Complementary GH release via different receptor pathways. Popular combination. This assessment has 95% confidence and is based on documented research data.
How should I time CJC-1295 (without DAC) and Ipamorelin?
CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and Ipamorelin has a half-life of ~2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.